Actively Recruiting

Phase 3
Age: 55Years - 85Years
All Genders
NCT06709014

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Led by Annovis Bio Inc. · Updated on 2026-05-13

760

Participants Needed

81

Research Sites

173 weeks

Total Duration

On this page

Sponsors

A

Annovis Bio Inc.

Lead Sponsor

P

Prevail Infoworks

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn about the safety of buntanetap/Posiphen. The main questions it aims to answer are: * Does buntanetap/Posiphen improve cognition as measured by ADAS-Cog13? * Does buntanetap/Posiphen improve function as measured by ADCS-iADL? * What medical issues do participants have, if any, when taking buntanetap/Posiphen? Researchers will compare buntanetap/Posiphen to a placebo (a look-alike substance that contains no drug) to see if buntanetap/Posiphen works to treat early Alzheimer's disease. Participants will: * Take buntanetap/Posiphen or a placebo every day for 18 months * Visit the clinic periodically for checkups, tests, and questionnaires (screening visits, enrollment, month 1, month 3, month 6, month 9, month 12, month 15, month 18), including a volumetric MRI at month 6 and month 18 * Complete pre- and post-clinic visit phone calls

CONDITIONS

Official Title

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Who Can Participate

Age: 55Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Alzheimer's disease according to 2024 National Institute on Aging and Alzheimer's Association criteria
  • Male or female aged 55 to 85 years
  • Mini-Mental State Examination (MMSE) score between 20 and 28 at screening and baseline
  • Clinical Dementia Rating (CDR) global score of 0.5 or 1 with memory box score at least 0.5
  • Positive amyloid beta status defined by plasma p-tau217 level at screening
  • MRI consistent with Alzheimer's disease diagnosis without significant abnormalities
  • Have a study partner in frequent contact who will provide consent and accompany to visits
  • Female participants of childbearing potential must have negative pregnancy test and agree to use effective contraception during and one month after the trial
  • Male participants must be sterile, sexually inactive, or agree to use barrier contraception and ensure female partners use effective contraception
  • Cognition and function sufficient to provide informed consent or with a legally authorized representative
  • No current suicidal ideation or recent suicide attempt
  • Stable permitted medications for at least 4 weeks prior to screening
  • Adequate vision and hearing to complete assessments
  • Participants previously exposed to buntanetap allowed after 28-day washout period
Not Eligible

You will not qualify if you...

  • History of unstable psychiatric disorders such as schizophrenia or bipolar disorder
  • Non-Alzheimer's dementia diagnoses
  • History of seizure disorder unless stable on medication
  • Brain MRI showing significant abnormalities like large infarcts or tumors
  • History or current long QT syndrome or abnormal ECG heart rhythms
  • Uncontrolled diabetes or significant kidney or liver impairment
  • Clinically significant abnormal lab values
  • Imminent risk of self-harm or harm to others
  • Recent cancer or malignant tumor within past year except stable cases
  • Moderate to severe alcohol or substance use disorder within past 5 years
  • Recent participation in another investigational drug trial within 4 weeks
  • Learning disability or developmental delay
  • Known allergy to the investigational drug or its components
  • Currently pregnant, breastfeeding, or lactating
  • Use of strong or moderate CYP3A4 inhibitors or inducers
  • Uncontrolled high or low blood pressure deemed medically significant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 81 locations

1

MD First Research

Chandler, Arizona, United States, 85286

Actively Recruiting

2

Xenoscience

Phoenix, Arizona, United States, 85004

Actively Recruiting

3

Clinical Endpoints

Scottsdale, Arizona, United States, 85258

Actively Recruiting

4

Advanced Research Center

Anaheim, California, United States, 92805

Actively Recruiting

5

Hope Clinical Research

Canoga Park, California, United States, 91303

Actively Recruiting

6

Sun Valley Research

Imperial, California, United States, 92251

Actively Recruiting

7

Mary S. Easton Center for Alzheimer's Research and Care, UCLA

Los Angeles, California, United States, 90095

Actively Recruiting

8

UC Davis Alzheimer's Disease Research Center

Sacramento, California, United States, 95816

Actively Recruiting

9

The Neuron Clinic

San Marcos, California, United States, 92069

Actively Recruiting

10

Mountain Neurological Center

Basalt, Colorado, United States, 81621

Actively Recruiting

11

CenExel Rocky Mountain

Englewood, Colorado, United States, 80113

Actively Recruiting

12

Research Center for Clinical Trials

Norwalk, Connecticut, United States, 06851

Actively Recruiting

13

Visionary Investigators Network

Aventura, Florida, United States, 33180

Actively Recruiting

14

SFM Clinical Research

Boca Raton, Florida, United States, 33487

Actively Recruiting

15

K2 Medical Research

Clermont, Florida, United States, 34711

Actively Recruiting

16

K2 Medical Research Daytona

Daytona Beach, Florida, United States, 32114

Actively Recruiting

17

Neuropsychiatric Research Center

Fort Myers, Florida, United States, 33912

Actively Recruiting

18

Velocity Clinical

Hallandale, Florida, United States, 33009

Actively Recruiting

19

Jacksonville Center for Clinical Research

Jacksonville, Florida, United States, 32216

Active, Not Recruiting

20

K2 Medical Research

Lady Lake, Florida, United States, 32159

Actively Recruiting

21

Headlands Research JEM

Lake Worth, Florida, United States, 33462

Actively Recruiting

22

Accel Research Sites Lakeland (Alcanza)

Lakeland, Florida, United States, 33803

Actively Recruiting

23

K2 Medical Research

Maitland, Florida, United States, 32751

Actively Recruiting

24

ClinCloud Clinical Research

Melbourne, Florida, United States, 32940

Actively Recruiting

25

Flourish Research/Merritt Island Medical Research

Merritt Island, Florida, United States, 32952

Actively Recruiting

26

Miami Jewish Health

Miami, Florida, United States, 33137

Actively Recruiting

27

Aqualane Clinical Research

Naples, Florida, United States, 34102

Actively Recruiting

28

Suncoast Clinical Research

New Port Richey, Florida, United States, 34652

Actively Recruiting

29

Conquest Research

Orlando, Florida, United States, 32832

Actively Recruiting

30

Axiom Brain Health, LLC

Tampa, Florida, United States, 33609

Actively Recruiting

31

Conquest Research

Winter Park, Florida, United States, 32789

Actively Recruiting

32

Accel Neurosciences

Decatur, Georgia, United States, 30030

Actively Recruiting

33

CARE (Center for Advanced Research & Education)

Gainesville, Georgia, United States, 30501

Actively Recruiting

34

Hawaii Pacific Neuroscience

Honolulu, Hawaii, United States, 96817

Actively Recruiting

35

Re:Cognition Chicago

Chicago, Illinois, United States, 60611

Actively Recruiting

36

Rush University Medical Center

Chicago, Illinois, United States, 60612

Actively Recruiting

37

Charter Research Chicago

Chicago, Illinois, United States, 60618

Actively Recruiting

38

Great Lakes Clinical Trials/Flourish Research

Chicago, Illinois, United States, 60640

Actively Recruiting

39

Southern Illinois University

Springfield, Illinois, United States, 62702

Actively Recruiting

40

JWM Research

Indianaopolis, Indiana, United States, 46256

Actively Recruiting

41

Ascension via Christi Research

Wichita, Kansas, United States, 37214

Actively Recruiting

42

Tandem Intermediate

Metairie, Louisiana, United States, 70006

Actively Recruiting

43

Headlands Research Pharmasite

Pikesville, Maryland, United States, 21208

Actively Recruiting

44

Neurology Center of New England, PC

Foxborough, Massachusetts, United States, 02035

Actively Recruiting

45

Headlands Research Easter Massachusetts

Plymouth, Massachusetts, United States, 02360

Actively Recruiting

46

Mayflower Clinical

Russells Mills, Massachusetts, United States, 02747

Actively Recruiting

47

Elixia MA

Springfield, Massachusetts, United States, 01103

Actively Recruiting

48

Quest Research Institute

Farmington Hills, Michigan, United States, 48334

Actively Recruiting

49

Precise Research Center

Flowood, Mississippi, United States, 39232

Actively Recruiting

50

Clinical Research Professionals - Headlands Research

Chesterfield, Missouri, United States, 63005

Actively Recruiting

51

Oasis Clinical Trials LLC

Las Vegas, Nevada, United States, 89121

Actively Recruiting

52

Cenexel Advanced Medical Research of New Jersey (AMRI)

Toms River, New Jersey, United States, 08755

Actively Recruiting

53

Advanced Clinical Institute

West Long Branch, New Jersey, United States, 07764

Actively Recruiting

54

Dent Neurologic Institute

Amherst, New York, United States, 14226

Actively Recruiting

55

SPRI

Brooklyn, New York, United States, 11235

Actively Recruiting

56

Neurological Associates of Long Island

Lake Success, New York, United States, 11042

Actively Recruiting

57

Parker Jewish Institute for Health Care and Rehab

New Hyde Park, New York, United States, 11040

Active, Not Recruiting

58

New York Neurology Associates

New York, New York, United States, 10003

Active, Not Recruiting

59

Richmond Behavioral Associates

Staten Island, New York, United States, 10314

Actively Recruiting

60

Ichor Research

Syracuse, New York, United States, 13210

Actively Recruiting

61

Duke University

Durham, North Carolina, United States, 27705

Actively Recruiting

62

AMC Research/Flourish Research

Matthews, North Carolina, United States, 28105

Actively Recruiting

63

Eximia Clinical Research

Raleigh, North Carolina, United States, 27607

Active, Not Recruiting

64

American Clinical Research Center

Beavercreek, Ohio, United States, 45432

Actively Recruiting

65

Valley Medical Research

Centerville, Ohio, United States, 45459

Actively Recruiting

66

Insight Clinical Trials

Independence, Ohio, United States, 44131

Actively Recruiting

67

Lynn Health Science Institute

Oklahoma City, Oklahoma, United States, 73112

Actively Recruiting

68

Summit Headlands

Portland, Oregon, United States, 97210

Actively Recruiting

69

Suburban Research Associates

Media, Pennsylvania, United States, 19063

Actively Recruiting

70

K2 Keystone

Plymouth Meeting, Pennsylvania, United States, 19462

Actively Recruiting

71

Rhode Island Mood and Memory Research Institute

East Providence, Rhode Island, United States, 02914

Actively Recruiting

72

Palmetto Primary Care & Specialty Physicians

Summerville, South Carolina, United States, 29486

Actively Recruiting

73

Neurology Clinic, P.C.

Cordova, Tennessee, United States, 38018

Actively Recruiting

74

K2 Medical Research Nashville

Nashville, Tennessee, United States, 37204

Actively Recruiting

75

Senior Adults Specialty Research

Austin, Texas, United States, 78757

Actively Recruiting

76

NeuroMind Clinical Trials

Houston, Texas, United States, 77094

Actively Recruiting

77

Central Texas Neurology Associates

Round Rock, Texas, United States, 78681

Actively Recruiting

78

Grayline Research Center

Wichita Falls, Texas, United States, 76309

Actively Recruiting

79

Memory Clinic, Inc.

Bennington, Vermont, United States, 05201

Actively Recruiting

80

Sana Research

Arlington, Virginia, United States, 22205

Actively Recruiting

81

Re:Cognition Fairfax

Fairfax, Virginia, United States, 22031

Actively Recruiting

Loading map...

Research Team

S

Sarah MacCallum, BA, BSN

CONTACT

A

Alexander Morin, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD | DecenTrialz